Key facts
- This page summarizes Donald Olds's Form 4 filing for Acasti Pharma Inc. (GRCE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Sep 2023, 15:54.
Donald Olds - 31 Aug 2023 Form 4 Insider Report for Acasti Pharma Inc. (GRCE)
- Reporting relationship
- Director
- Issuer ticker
- GRCE
- Reported as of
- 31 Aug 2023
- Net transaction value
- +$781
- SEC form
- 4
- Accepted by SEC
- 05 Sep 2023, 15:54:48 UTC
- Prior SEC filing
- 18 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Prashant Kohli, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Donald Olds filed Form 4 for Acasti Pharma Inc. (GRCE) on 05 Sep 2023.
Change
- Previous filing in this sequence was filed on 18 Jul 2023.
- Current net transaction value: +$781.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACST
transaction
Common Shares
Purchase
- Transaction value
- $781
- Shares
- +381
- Change %
- Price
- $2.05
- Shares after
- 381
- Date
- 31 Aug 2023
- Ownership
- Direct
ACST
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 792
- Date
- 31 Aug 2023
- Ownership
- Ofra Aslan (Spouse)
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These indirect holdings have been adjusted to give effect to the Company's 1-for-8 reverse stock split, effective August 31, 2021, and the Company's 1-for-6 reverse stock split, effective July 10, 2023.
Footnote F2
792 common shares held by Mr. Olds' wife, Ofra Aslan. Mr. Olds disclaims beneficial ownership of the common shares held by his wife and this report shall not be deemed an admission that Mr. Olds is a beneficial owner of such for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.